Clinical Research Fund OÜ

16114591

Company info

Clinical Research Fund OÜ

16114591

crfou.com - Informationen zum Thema crfou.http://crfou.comcrfou.com - Informationen zum Thema crfou.

crfou.com ist Ihre erste und beste Informationsquelle über crfou. Hier finden Sie auch weitere interessante Links. Wir hoffen, dass Sie bei Ihrer Suche erfolgreich sind!

General info

Name

Clinical Research Fund OÜ

Registry code

16114591

VAT number

EE102341670

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

04.12.2020 (5)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

74901 - Other professional, scientific and technical activities n.e.c.

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

0

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner

B2baltics consulting OÜ

14104246

- Contact person -

Nathan Andrew Dundovic

- Board member Direct ownership

Sophie Marie Dundovic

- Board member Direct ownership

Financial info

2021
13.04.2023
2022
08.01.2024
2023
12.06.2024
Total Revenue 37 955 € 222 827 € 1 077 172 €
Net profit (loss) for the period 30 634 € 185 055 € 742 956 €
Profit Margin 81% 83% 69%
Current Assets 31 474 € 227 372 € 963 681 €
Fixed Assets - - -
Total Assets 31 474 € 227 372 € 963 681 €
Current Liabilities 840 € 11 683 € 5 036 €
Non Current Liabilities - - -
Total Liabilities - - -
Share Capital - - -
Equity 30 634 € 215 689 € 958 645 €
Employees 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2025 Q4 252 524 € 227 € 0 € -
2025 Q3 109 € - - -
2025 Q2 1 269 € 398 € 0 € -
2025 Q1 135 143 € 134 € 0 € -
2024 Q4 423 975 € 158 € 0 € -
2024 Q3 248 934 € 74 € 0 € -
2024 Q2 226 165 € - - -
2024 Q1 174 052 € 223 € 0 € -
2023 Q4 89 716 € - - -
2023 Q3 191 738 € 228 € 0 € -
2023 Q2 72 089 € - - -
2023 Q1 34 160 € - - -
2022 Q4 28 763 € - - -
2022 Q3 33 777 € - - -
2022 Q2 38 279 € - - -
2022 Q1 -699 € - - -